GWPH GW Pharmaceuticals PLC (GWPH) Q2 2020 Earnings Call Transcript 6 years ago GW Pharmaceuticals PLC (NASDAQ: GWPH) Q2 2020 earnings call dated August 06, 2020 Corporate Participants: Stephen Schultz — Vice President of Investor… GW Pharmaceuticals (GWPH): Investments in manufacturing and international expansion serve as strong growth drivers 6 years ago GW Pharmaceuticals plc (NASDAQ: GWPH) has seen its stock gain over 17% in the past one month. The company delivered… GW Pharmaceuticals PLC (NASDAQ: GWPH) Q1 2020 Earnings Call Transcript 6 years ago GW Pharmaceuticals PLC (GWPH) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Stephen Schultz — Vice President, Investor Relations Justin… Stock Analysis: GW Pharma (GWPH) offers irresistible upside potential 6 years ago For GW Pharmaceuticals (NASDAQ: GWPH), the main growth strategy for the current fiscal year is to expand its product pipeline… GW Pharma (GWPH) Q4 loss narrows on strong sales; set to launch Epidiolex in Europe 6 years ago GW Pharmaceuticals (NASDAQ: GWPH) reported a narrower net loss for the fourth quarter of 2019 as net sales rose sharply,… What to look for when GW Pharmaceuticals (GWPH) reports Q4 earnings 6 years ago GW Pharmaceuticals plc (NASDAQ: GWPH) is slated to report fourth quarter 2019 earnings results on Tuesday, February 25, after the… GW Pharmaceuticals (GWPH) posts better-than-expected Q3 results 6 years ago GW Pharmaceuticals (NASDAQ: GWPH) beat revenue estimates and reported a narrower-than-expected loss for the third quarter of 2019. Despite the beat, the…